Brind.

Andrew King was appointed Chief Scientific Officer at Jade Biosciences on September 2, 2025.

2 reports, 1 independent Updated Sep 2
Gone quiet
Reports
2
Developments
1
Repetition
50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Andrew King was appointed Chief Scientific Officer at Jade Biosciences on September 2, 2025.

Who's involved

What this event is mainly about
Andrew King

Keep exploring

The entities involved

  • Andrew King

    researcher (ORCID 0000-0001-7175-2718)

    Nothing else this week.

Coverage

Newest first; wire copies grouped
  • GlobeNewswireJade Biosciences Announces First Cohort Dosed in Phase 1 Healthy Volunteer Clinical Trial of JADE101, a Novel and Potentially Best-in-Class Anti-APRIL Monoclonal Antibody Being Evaluated for the Treat
  • Unknown outlet